- Home
- CLPT
as 02-21-2025 4:00pm EST
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, and ClearPoint Therapeutic Solutions.
Upcoming Earnings Alert:
Get ready for potential market movements as ClearPoint Neuro Inc. CLPT prepares to release earnings report on 26 Feb 2025.
| Founded: | 1998 | Country: | United States |
| Employees: | N/A | City: | SOLANA BEACH |
| Market Cap: | 412.7M | IPO Year: | N/A |
| Target Price: | $19.67 | AVG Volume (30 days): | 174.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.69 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.11 - $19.22 | Next Earning Date: | 02-26-2025 |
| Revenue: | $30,429,000 | Revenue Growth: | 36.34% |
| Revenue Growth (this year): | 35.56% | Revenue Growth (next year): | 21.86% |
Latest ClearPoint Neuro Inc. News
CLPT Breaking Stock News: Dive into CLPT Ticker-Specific Updates for Smart Investing
Simply Wall St.
2 days ago
While institutions own 33% of ClearPoint Neuro, Inc. (NASDAQ:CLPT), individual investors are its largest shareholders with 59% ownership
ACCESS Newswire
8 days ago
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025
ACCESS Newswire
10 days ago
ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula
TipRanks
24 days ago
ClearPoint Neuro price target raised to $20 from $15 at B. Riley
Insider Monkey
25 days ago
ClearPoint Neuro, Inc. (CLPT): A Bull Case Theory
ACCESS Newswire
a month ago
ClearPoint Neuro Announces FDA Clearance for ClearPoint Navigation Software Version 3.0
ACCESSWIRE
3 months ago
ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain
Simply Wall St.
3 months ago
The ClearPoint Neuro, Inc. (NASDAQ:CLPT) Third-Quarter Results Are Out And Analysts Have Published New Forecasts
Compare CLPT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CLPT ClearPoint Neuro Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.